The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways
Health Law Advisor
MARCH 7, 2023
Telemedicine Prescribing During the COVID-19 PHE During the COVID-19 PHE, among many other regulatory flexibilities, federal and state prescribing requirements were relaxed. This deadline came and went, also without meaningful action taken by DEA.
Let's personalize your content